SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-207749
Filing Date
2024-08-27
Accepted
2024-08-27 16:01:53
Documents
13
Period of Report
2024-08-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d890897d8k.htm   iXBRL 8-K 26101
  Complete submission text file 0001193125-24-207749.txt   148195

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nexi-20240821.xsd EX-101.SCH 2502
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nexi-20240821_lab.xml EX-101.LAB 17946
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nexi-20240821_pre.xml EX-101.PRE 11229
16 EXTRACTED XBRL INSTANCE DOCUMENT d890897d8k_htm.xml XML 3753
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40045 | Film No.: 241248939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)